Vilon dose range
The amounts people commonly use, from the low end to the high end, with syringe units, schedule and half-life. The 7 published studies are one click away.
Animal studies only Bioregulators Also called KE, Lys-Glu
Common use ranges
From user guides and clinic write-ups. No drug label exists, and no study has tested these amounts in people. Guides disagree widely. One puts the injected course at 100 to 200 mcg a day, another at 10 mg a day. Sources are community and vendor guides only. No approved label exists in any country we found, and the published research comes almost entirely from one Russian research group.
Sources disagree, or there are very few. The amounts below come from a small number of guides, and they do not line up well. Treat every number on this page as uncertain, and check each source yourself.
- Half-life
- Not measured in any published study
- How it is taken
- Shot under the skin (subcutaneous), or oral capsule
- How long people use it
- 10 to 20 days in a row by injection, or 10 to 30 days by mouth. Repeated 1 to 3 times a year, every 3 to 6 months.
- Mixing used for the units
- 20 mg vial + 2 mL water. 1 unit on a U-100 insulin syringe = 100 mcg.
Pick your vial size and how much water you add. The units below change to match.
20 mg vial + 2 mL water: 1 unit = 100 mcg
| Tier | Each dose | Syringe units20 mg vial + 2 mL water | How often | Schedule | Vial lastsat this tier |
|---|---|---|---|---|---|
| Starting [1] | 100 mcg | 1 units 0.01 mL | once a day | 100 mcg under the skin once a day for 10 to 20 days. One guide gives as little as 10 mcg every other day. | 6+ weeks |
| Typical [2] | 200 mcg | 2 units 0.02 mL | once a day | 100 to 200 mcg under the skin once a day for 10 to 20 days. | 6+ weeks |
| Higher [3] | 10 mg | 100 units 1.00 mL | once a day | 10 mg under the skin once a day for 10 to 20 days. | 2 days |
| Oral Starting [4] | 100 mcg | Not a syringe dose | once a day | 100 to 200 mcg by mouth once a day for 10 to 30 days. | |
| Oral Typical [5] | 10 mg | Not a syringe dose | once a day | 1 to 2 capsules (10 to 20 mg) by mouth once a day for 10 to 30 days. | |
| Oral Higher [6] | 20 mg | Not a syringe dose | once a day | 20 mg by mouth once a day, the top of the 10 to 20 mg range. |
Good to know
- The mouse studies used very small amounts, about 10 mcg per kg.
- Oral strengths vary a lot by maker. Some packs list capsules, not milligrams, so the label on the box matters more than any range here.
Sources for these amounts
- Starting: Outliyr Vilon report · Peptide Assistant, Vilon
- Typical: Outliyr Vilon report
- Higher: Peptide DB, Vilon
- Oral Starting: Outliyr Vilon report
- Oral Typical: Peptide Assistant, Vilon · Peptide DB, Vilon
- Oral Higher: Peptide Assistant, Vilon · Peptide DB, Vilon
How long people use it: Outliyr Vilon report · Peptide Assistant, Vilon · Peptide DB, Vilon · Khavinson bioregulator guide (IPS News)
Half-life: PubMed search, vilon with pharmacokinetics or half-life, no relevant hits
Take the Vilon chart with you
Get a one-page printable chart for Vilon, with the syringe units for each vial and water mix. We can also email you when a new Vilon study is published.
This page shows what labels, clinics and users report, and what studies gave. It is not medical advice and not a recommendation for anyone. Many of these compounds are not approved for human use. Check your own medicines and lab work with a licensed clinician before using anything.
See the science: 7 published studies
No human dose data. No published human study of Vilon states an amount given. Every figure on this page comes from animal studies.
Amounts given to animals in studies
Read this first. Diabetes patients were given vilon in two Russian studies but no abstract states the amount. The mouse lifespan study gives no amount in the abstract. The rat dose is per animal, not per kg.
Every study used for this page
Proof grade: Animal studies only. No human dose data has been published. Amounts are quoted as each study reported them. Where the abstract does not state an amount, the row says so.
| Study | Who was studied | Amount given, as reported | Route | How often | How long | What the authors reported |
|---|---|---|---|---|---|---|
| PMID 18306698Kuznik et al, Adv Gerontol 2007 | Human, type 1 diabetes patients of different ages (n not in abstract) | Not stated in the abstract | Not in abstract | Not in abstract | Not in abstract | Added to standard care. Better clotting balance and often lower insulin need |
| PMID 17152731Kuznik et al, Adv Gerontol 2006 | Human, type 1 diabetes patients of different ages (n not in abstract) | Not stated in the abstract | Not in abstract | Not in abstract | Not in abstract | Reduced or removed signs of low-grade DIC. Weaker effect in elderly with severe disease |
| PMID 11140587Khavinson et al, Bull Exp Biol Med 2000 | Mouse, female CBA from 6 months old (n not in abstract) | Not stated in the abstract | Under the skin | Not in abstract | Long-term | Longer lifespan, more endurance, fewer spontaneous tumours. No harm seen |
| PMID 16308980Pliss et al, Vopr Onkol 2005 | Mouse, dimethylhydrazine cancer model (n not in abstract) | 10 mcg/kg | Not in abstract | Not in abstract | Not in abstract | Tumours in 14.3% vs 60% of controls |
| PMID 17152729Kudriavtseva et al, Adv Gerontol 2006 | Rat, old males, half-castrated model (n not in abstract) | 50 mcg per rat | Not in abstract | "Regular" (schedule not in abstract) | Not in abstract | Better sexual function, lower prolactin |
| PMID 11586406Pliss et al, Bull Exp Biol Med 2001 | Rat, chemically induced bladder cancer (n not in abstract) | Not stated in the abstract | Not in abstract | Not in abstract | Not in abstract | Tumours in 56% vs 75.5% of controls |
| PMID 12587272Koplik et al, Ross Fiziol Zh 2002 | Rat, male Wistar, emotional stress (n not in abstract) | Not stated in the abstract | Into the belly (IP) | Not in abstract | Not in abstract | More stress resistance, less adrenal growth and thymus shrinkage |
How to read the study numbers
- One study, one group. Each figure is what one team chose for its own participants or animals.
- Route matters. An amount given into a vein (IV) is not the same as the same amount under the skin, in the nose or by mouth.
- Animals are not small people. An animal amount is shown as the study gave it. It is not a human amount.
- Short studies. Many studies ran days or weeks. They do not show what happens over longer use.
Common questions
Is there a human dose for Vilon?
No published human study of Vilon states an amount given. The figures on this page come from animal studies only.
Where do these Vilon numbers come from?
From 7 published studies, each linked to its PubMed or ClinicalTrials.gov record. Every figure was checked against the study abstract or its open full text. Proof grade: Animal studies only.
How long does Vilon stay in the body?
No published study has measured the half-life of Vilon, so nobody knows exactly how long one dose stays in the blood.
Is this a recommendation for how much Vilon to use?
No. This page shows the amounts reported by drug labels, clinics and users, next to what researchers gave in studies. It is not medical advice and not a recommendation for anyone. Talk to a licensed clinician before using any of it.